Photodynamic therapy for the treatment of recurrent herpes labialis: Preliminary results

General Dentistry

Volumn 57, Issue 4, 2009, Pages 415-419

  Sperandio, Felipe Fornias ^a   Marotti, Juliana ^b   Aranha, Ana Cecilia Correa ^b   De Paula Eduardo, Carlos ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Department of Prosthodontics ^*  (United States)

^c Department of Restorative Dentistry   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENE BLUE; PHOTOSENSITIZING AGENT;

ADULT; ARTICLE; CASE REPORT; DIODE LASER; FEMALE; HERPES LABIALIS; HUMAN; LOW LEVEL LASER THERAPY; PHOTOCHEMOTHERAPY; RECURRENT DISEASE;

ADULT; FEMALE; HERPES LABIALIS; HUMANS; LASER THERAPY, LOW-LEVEL; LASERS, SEMICONDUCTOR; METHYLENE BLUE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RECURRENCE; YOUNG ADULT;

EID: 77952032704     PISSN: 03636771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Embil JA, Stephens RG, Manuel FR. Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents. Can Med Assoc J 1975; 113(7): 627-630.
2. Young SK, Rowe NH, Buchanan RA. A clinical study for the control of facial mucocutaneous herpes virus infections. I. Characterization of natural history in a professional school population. Oral Surg Oral Med Oral Pathol 1976; 41(4): 498-507.
3. Miller CS, Danaher RJ, Jacob RJ. Molecular aspects of herpes simplex virus I latency, reactivation and recurrence. Crit Rev Oral Biol Med 1998; 9(4): 541-562. (Pubitemid 29402015)
4. Woo SB, Challacombe SJ. Management of recurrent oral herpes simplex infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103 Suppl:S12. e1-e18.
5. Sciubba JJ. Oral mucosal diseases in the office setting-Part I: Aphthous stomatitis and herpes simplex infections. Gen Dent 2007; 55(4): 347-354.
6. Arduino PG, Porter SR. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: Review of its management. Oral Dis 2006; 12(3): 254-270.
7. Spruance SL, Nett R, Marbury T, Wolff R, Johnson J, Spaulding J. Acyclovir cream for the treatment of herpes simplex labialis: Results of two double blind, placebo-controlled trials. Antimicrob Agents Chemother 2002; 46(7): 2238-2243.
8. Schindl A, Neumann R. Low-intensity laser therapy is an effective treatment for recurrent herpes simplex infection. Results from a randomized double-blind placebo-controlled study. J Invest Dermatol 1999; 113(2): 221-223.
9. Smetana Z, Malik Z, Orenstein A, Mendelson E, Ben-Hur E. Treatment of viral infections with 5-aminolevulinic acid and light. Lasers Surg Med 1997; 21(4): 351-358.
10. Chan Y, Lai CH. Bactericidal effects of different laser wavelengths on periodontopathic germs in photodynamic therapy. Lasers Med Sci 2003; 18(1): 51-55. (Pubitemid 36401972)
11. Genina EA. Methylene blue mediated laser therapy of maxillary sinusitis. Laser Phys 2006; 16: 1128-1133.
12. Meisel P, Kocher T. Photodynamic therapy for periodontal diseases: State of the art. J Photochem Photobiol B 2005; 79(2): 159-170. (Pubitemid 40614108)
13. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Photodynamic therapy. J Natl Cancer Inst 1998; 90(12): 889-905.
14. Ackroyd R, Brown NJ, Davis MF, Stephenson TJ, Stoddard CJ, Reed MW. Aminolaevulinic acid-induced photodynamic therapy in the treatment of dysplastic Barrett's oesophagus and adenocarcinoma. Lasers Med Sci 1999; 14: 278-285.
15. Hiatt CW, Kaufman E, Helprin JJ, Baron S. Inactivation of viruses by the photodynamic action of toluidine blue. J Immunol 1960; 84: 480-484.
16. Wallis C, Melnick JL. Irreversible photosensitization of viruses. Virology 1964; 23: 520-527.
17. Wallis C, Melnick JL. Photodynamic inactivation of animal viruses: A review. Photochem Photobiol 1965; 4(2): 159-170.
18. Melnick JL, Wallis C. Photodynamic inactivation of herpes virus: A status report. Ann N Y Acad Sci 1977; 284: 171-181.
19. Kelty CJ, Brown NJ, Reed MW, Ackroyd R. The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis. Photochem Photobiol Sci 2002; 1(3): 158-168.
20. Schultz EW, Krueger AP. Inactivation of Staphylococcus bacteriophage by methylene blue. Proc Soc Exp Biol Med 1928; 26: 100-101.
21. Wilson M, Dobson J, Harvey W. Sensitization of oral bacteria to killing by low-power laser radiation. Curr Microbiol 1992; 25(2): 77-81.
22. Hsi RA, Rosenthal Dl, Glatstein E. Photodynamic therapy in the treatment of cancer: Current state of the art. Drugs 1999; 57(5): 725-734. (Pubitemid 29231888)
23. Schnipper LE, Lewin AA, Swartz M, Crumpacker CS. Mechanisms of photodynamic inactivation of herpes simplex viruses: Comparison between methylene blue, light plus electricity, and hematoporhyrin plus light. J Clin Invest 1980; 65(2): 432-438. (Pubitemid 10159873)
24. Freeman DJ, Sheth NV, Spruance SL. Failure of topical acyclovir in ointment to penetrate human skin. Antimicrob Agents Chemother 1986; 29(5): 730-732.
25. Femiano F, Gombos F, Scully C. Recurrent herpes labialis: Efficacy of topical therapy with penciclovir compared with acyclovir (aciclovir). Oral Dis 2001 ;7(1): 31-33.
26. Lin L, Chen XS, Cui PG, Wang JB, Guo ZP, Lu NZ, Bi ZG, Jia H, Yang XY; Topical Penciclovir Clinical Study Group. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: A randomized, double-blind, multicentre, aciclovir-controlled trial. J Dermatolog Treat 2002; 13(2): 67-72.
27. Sciubba JJ. Herpes simplex and aphthous ulcerations: Presentation, diagnosis and management-An update. Gen Dent 2003; 51(6): 510-516.
28. Whitley RJ, Kimberlin DW, Roizman B. Herpes simplex viruses. Clin Infect Dis 1998; 26(3): 541-553.
29. Sarkar S, Wilson M. Lethal photosensitization of bacteria in subgingival plaque from patients with chronic periodontitis. J Periodont Res 1993; 28(3): 204-210.
30. Spikes JD, Jori G. Photodynamic therapy of tumors and other diseases using porphyrins. Lasers Med Sci 1987; 2: 3-15.